|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Thalomid (Thalidomide). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (459)
Cases resulting in a serious event (453)
Cases resulting in death (132)
Cases resulting in life threatening events (4)
Cases resulting in hospitalization (220)
Cases resulting in disability (12)
Cases resulting in other serious reactions (225)
Below is a sample of reports where side effects / adverse reactions may be related to Thalomid (Thalidomide). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 73 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-31
Patient: 73 year old female
Adverse reactions / side effects: Productive Cough, Confusional State, Blood Bilirubin Increased, Performance Status Decreased, Pain, Malignant Neoplasm Progression, Blood Albumin Decreased, Multiple Myeloma, Fall, Drug Toxicity, Subdural Haematoma, Drug Tolerance Decreased, Fatigue, Protein Total Increased, Blood Glucose Increased, Blood Alkaline Phosphatase Increased, Dyspnoea, Alanine Aminotransferase Increased, Asthenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Dexamethasone TAB
Adverse event in 49 year old female receiving Thalomid (Thalidomide)
Reported by a physician from Canada on 2007-10-30
Patient: 49 year old female
Adverse reactions / side effects: Blood Human Chorionic Gonadotropin Increased
Suspect drug(s):
Thalomid
Dosage: 400 mg, 8 in 1 d, oral; 400 mg, daily, oral; 200 mg, 4 in 1 d, oral; 200 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
End date: 2004-07-01
Thalomid
Dosage: 400 mg, 8 in 1 d, oral; 400 mg, daily, oral; 200 mg, 4 in 1 d, oral; 200 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2004-07-01
Thalomid
Dosage: 400 mg, 8 in 1 d, oral; 400 mg, daily, oral; 200 mg, 4 in 1 d, oral; 200 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-01-01
Thalomid
Dosage: 400 mg, 8 in 1 d, oral; 400 mg, daily, oral; 200 mg, 4 in 1 d, oral; 200 mg, 4 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-01-01
Thalomid
Thalomid
Thalomid
Other drugs received by patient: Pamidronate Disodium
Adverse event in 72 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-30
Patient: 72 year old female
Adverse reactions / side effects: Spinal Cord Compression, Disease Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in 76 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-29
Patient: 76 year old male
Adverse reactions / side effects: Refractory Anaemia, Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: death
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Decadron
Adverse event in 56 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-29
Patient: 56 year old male
Adverse reactions / side effects: Hepatic Failure
Adverse event resulted in: death
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in 35 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-29
Patient: 35 year old male
Adverse reactions / side effects: Weight Decreased, Light Chain Disease, Hepatic Failure, Multiple Myeloma, Constipation, Disease Progression, Fatigue, Anorexia, Platelet Count Decreased, Dizziness, Asthenia, Thrombocytopenia
Adverse event resulted in: death
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Decadron; Omeprazole; Oxycontin; Bactrim; Acyclovir; Senokot; Allopurinol; Doxorubicin HCL; Bortezomib (Bortezomib)
Adverse event in 55 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-29
Patient: 55 year old male
Adverse reactions / side effects: Pain in JAW
Suspect drug(s):
Thalomid
Dosage: 300 mg, daily, oral; 400 mg, daily, oral; 200 mg, daily, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2003-01-13
End date: 2003-02-14
Thalomid
Dosage: 300 mg, daily, oral; 400 mg, daily, oral; 200 mg, daily, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2003-03-14
End date: 2004-01-02
Thalomid
Dosage: 300 mg, daily, oral; 400 mg, daily, oral; 200 mg, daily, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2004-02-20
End date: 2007-03-22
Adverse event in 46 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-25
Patient: 46 year old female
Adverse reactions / side effects: Pregnancy Test Urine Positive, Blood Human Chorionic Gonadotropin Increased
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in 11 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-25
Patient: 11 year old female
Adverse reactions / side effects: Mass
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in 79 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-24
Patient: 79 year old male
Adverse reactions / side effects: Blood Urea Increased, Multiple Myeloma, Fall, Loss of Consciousness, Disease Progression, Haemoglobin Decreased, Blood Immunoglobulin G Increased, Haematocrit Decreased, RED Blood Cell Count Decreased, Limb Injury, NO Therapeutic Response, Platelet Count Decreased
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Cozaar; Lipitor; Nexium; Colace (Docusate Sodium); B Complex ELX; Magnesium (Magnesium); Coumadin; Selenium (Selenium); SAW Palmetto (Serenoa Repens)
Adverse event in 76 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-24
Patient: 76 year old female
Adverse reactions / side effects: Fluid Overload, Gastrointestinal Ulcer, Gastrointestinal Haemorrhage, Pulmonary Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Arimidex; Aredia; Lotrel; Lasix; Senokot; Aspirin; Protonix
Adverse event in 59 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-23
Patient: 59 year old female
Adverse reactions / side effects: Weight Decreased, Pneumonia, Fatigue, Malaise, Sepsis
Adverse event resulted in: death
Suspect drug(s):
Revlimid
Dosage: 25 mg, qd, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-04-16
End date: 2007-04-30
Thalomid
Dosage: 50-100-200 mg, qhs x 2 weeks, oral; 200 mg, qhs, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-02-19
End date: 2007-04-16
Thalomid
Dosage: 50-100-200 mg, qhs x 2 weeks, oral; 200 mg, qhs, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-05-14
Adverse event in 59 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-23
Patient: 59 year old male
Adverse reactions / side effects: Renal Failure, Peptic Ulcer Haemorrhage, Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2001-10-25
End date: 2001-01-01
Thalomid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2001-09-27
End date: 2001-10-05
Thalomid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2001-10-05
End date: 2001-10-25
Thalomid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2001-12-13
End date: 2002-01-01
Thalomid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2002-04-22
End date: 2005-01-01
Adverse event in 47 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-23
Patient: 47 year old female
Adverse reactions / side effects: Renal Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-23
Patient: female
Adverse reactions / side effects: Cardiac Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-22
Patient: male
Adverse reactions / side effects: Stem Cell Transplant, Stomach Discomfort, Sepsis, Complications of Transplant Surgery, Organ Failure
Adverse event resulted in: death
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in male receiving Thalomid (Thalidomide)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-22
Patient: male, weighing 79.4 kg (174.6 pounds)
Adverse reactions / side effects: Small Intestinal Obstruction, Incisional Hernia
Adverse event resulted in: hospitalization
Suspect drug(s):
Temodar
Dosage: 100 mg qhs for 21 days po
Administration route: Oral
Indication: Renal Cell Carcinoma Stage IV
Start date: 2007-02-15
End date: 2007-10-12
Thalomid
Dosage: 100 mg qhs for 28 days po
Administration route: Oral
Indication: Renal Cell Carcinoma Stage IV
Start date: 2007-02-08
End date: 2007-10-12
Other drugs received by patient: Xeloda; Toprol-XL; Coumadin; Morphine; Percocet
Adverse event in 77 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-22
Patient: 77 year old male
Adverse reactions / side effects: Lung Neoplasm Malignant, Malignant Neoplasm Progression, Multiple Myeloma
Adverse event resulted in: death
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in 77 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-22
Patient: 77 year old male
Adverse reactions / side effects: Subdural Haematoma
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid
Dosage: 100 mg, 1 in 1 d, oral; 50 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2002-02-22
End date: 2003-03-01
Thalomid
Dosage: 100 mg, 1 in 1 d, oral; 50 mg, 1 in 1 d, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2004-01-28
Adverse event in 47 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-22
Patient: 47 year old male
Adverse reactions / side effects: Haemorrhage Intracranial, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Renagel; Colace (Docusate Sodium); Nexium; Erythropoietin (Erythropoietin)
Adverse event in 43 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-19
Patient: 43 year old female
Adverse reactions / side effects: Spinal Cord Compression, Sepsis, Anaemia, Malignant Neoplasm Progression, Multiple Myeloma, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Suspect drug(s):
Thalomid (Thalidomide)
Adverse event in 56 year old female receiving Thalomid (Thalidomide)
Reported by a physician from United Kingdom on 2007-10-19
Patient: 56 year old female
Adverse reactions / side effects: Asthma, Bronchospasm
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid
Dosage: 400 mg, 8 in 1 d, oral, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-09-11
End date: 2007-10-02
Thalomid
Dosage: 400 mg, 8 in 1 d, oral, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-10-08
End date: 2007-10-09
Adverse event in 66 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-19
Patient: 66 year old male
Adverse reactions / side effects: Neuropathy, Diabetes Mellitus, Pulmonary Fibrosis
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Thalomid (Thalidomide)
Other drugs received by patient: Dexamethasone TAB; Erythropoetin (Epoetin Alfa)
Adverse event in 51 year old male receiving Thalomid (Thalidomide)
Reported by a physician from Canada on 2007-10-19
Patient: 51 year old male
Adverse reactions / side effects: Pontiac Fever, Pneumonia Legionella, Oral Candidiasis, Anaemia, Lymphopenia, Opportunistic Infection, Bradycardia, Lung Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
Prednisone TAB
Dosage: 10 mg, qd
Indication: Multiple Myeloma
Thalomid
Dosage: 200 mg/kg, qd, oral
Administration route: Oral
Indication: Multiple Myeloma
Adverse event in 71 year old male receiving Thalomid (Thalidomide)
Reported by a physician from United States on 2007-10-19
Patient: 71 year old male
Adverse reactions / side effects: Confusional State, Fluid Imbalance, Diabetes Mellitus, Renal Failure Chronic, Somnolence, Cardiac Disorder, Haemoglobin Decreased, Dehydration, International Normalised Ratio Decreased, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Thalomid
Dosage: 100 mg, 1 in 1 d, oral; 100mg-200mg, 100mg x 7 days then 200 mgx21 days, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-06-01
End date: 2007-06-24
Thalomid
Dosage: 100 mg, 1 in 1 d, oral; 100mg-200mg, 100mg x 7 days then 200 mgx21 days, oral
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-08-15
End date: 2007-09-11
Other drugs received by patient: Warfarin Sodium; Aspirin; Decadron
|
